type-1

Documents about type-1

• Cell type-specific transcriptional responses of plants to salinity#433327HAL (France)
• Redox Genetic Risk Score and the Incidence of End-Stage Kidney Disease in People with Type 1 Diabetes#280246HAL (France)
• Threshold Suspend in Pediatrics at Home#148682ClinicalTrials.gov
• Imaging Inflammation in Autoimmune Diabetes#162396ClinicalTrials.gov
• Primary Intervention With Mucosal Insulin#238287ClinicalTrials.gov
• MyT1DHero: an mHealth Intervention for Type 1 Diabetes#279640ClinicalTrials.gov
• Artificial Pancreas in Pediatric Patients (PEDarPAN)#405281ClinicalTrials.gov
• Mobile Communication Technology for Adolescents With Diabetes#407830ClinicalTrials.gov
• Can Glucose Monitoring Improve (CGMi Study)#429688ClinicalTrials.gov
• The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Lansoprazole for Insulin Independence Among Patients With Existing Type 1 Diabetes#290928ClinicalTrials.gov
• A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SAR438544 in Comparison to Glucagon in Type 1 Diabetes Mellitus Patients Under Induced Hypoglycemia#398245ClinicalTrials.gov
• A Review of Informed Consent for Porcine Islet Xenotransplantation to Treat Type 1 Diabetes.#409742PubMed
• Rôle de l'inflammation et du facteur de transcription Foxo1 dans l'exhaustion des cellules T au cours des réponses anti-tumorales#326245HAL (France)
• Comparison of Noninvasive Blood Glucose Concentrations Relative to Finger Capillary Blood Glucose References#141208ClinicalTrials.gov
• Accuracy of Dexcom G6® and FreeStyle Libre® Sensors in Standardized Hypoxemia Conditions#180292ClinicalTrials.gov
• A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes Mellitus#184815ClinicalTrials.gov
• A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.#226211ClinicalTrials.gov
• Effectiveness and Safety Study of the Abbott Sensor Based Glucose Monitoring Systems#234569ClinicalTrials.gov
• Observational Study With Mixtard® 30 NovoLet® to Assess Patient Satisfaction#314280ClinicalTrials.gov
• Social Determinants of Health and Continuous Glucose Monitoring Metrics in Type 1 or Type 2 Diabetes.#338709NCBI PubMed Central
• Comparison of SmartGuard vs Temp Target in Patients With Type 1 Diabetes Users of Advanced Hybrid Closed Loop System (AHCL) in Anaerobic Physical Activity.#154845ClinicalTrials.gov
• An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 1 Diabetes Mellitus#230312ClinicalTrials.gov
• Additional Autoimmune Diseases With Type 1 Diabetes in Pediatrics at Diabetes Diagnosis and During Follow-up#279673ClinicalTrials.gov
• How effective are CBT and CBT-based interventions in Type 1 and Type 2 diabetes? An umbrella review.#8998NCBI PubMed Central
• GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy#136225ClinicalTrials.gov
• DIABETES MELLITUS: PATHOPHYSIOLOGY, DIAGNOSIS AND EMERGING THERAPEUTIC STRATEGIES#210168Zenodo (CERN)
• Effect of Metformin and Cholecystokinin-mediated Gallbladder Emptying on GLP-1 Secretion in Type 2 Diabetes#373778ClinicalTrials.gov
• MODY in Young-onset Diabetes in Different Ethnicities#383519ClinicalTrials.gov
• Study to Determine the Relationship Between Exercise and Hypoglycemia in Children With Type 1 Diabetes#432832ClinicalTrials.gov
• Dynamical Analysis of Impeller-type Rice Husker (Part 1)#69594J-STAGE (Japan)
• Metabolic Adaptation to High-frequent Hypoglycaemia in Type 1 Diabetes#217192ClinicalTrials.gov
• Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh#303577ClinicalTrials.gov
• UK MyREMEDY Clinical Trial#325252ClinicalTrials.gov
• In Clinic Evaluation of the PLGM Feature#329478ClinicalTrials.gov
• The Loop Observational Study#394694ClinicalTrials.gov
• GLP-1 Infusion and Long-Time Fasting#411346ClinicalTrials.gov
• To Evaluate the Bioavailability of a Tablet of AZD1656#435697ClinicalTrials.gov
• T1DM Immunotherapy Using Polyclonal Tregs + IL-2#435736ClinicalTrials.gov
• Evaluation of an Early Screener to Identify Long-term Problems With Regard to Metabolic Control and Treatment Adherence Among Children and Adolescents With Type 1 Diabetes#287481ClinicalTrials.gov
• Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D)#377367ClinicalTrials.gov
• Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide#141166ClinicalTrials.gov
• A Trial Evaluating Compatibility and Safety of FIAsp and Insulin Aspart With an External Continuous Subcutaneous Insulin Infusion System in Adult Subjects With Type 1 Diabetes#261449ClinicalTrials.gov
• A Double-blinded, Randomised, Two -Period Crossover Euglycemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Insulin Lispro and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes#377361ClinicalTrials.gov
• Effect of Immediate Hemoglobin A1c on Glycemic Control in Children With Type I Diabetes Mellitus#67781ClinicalTrials.gov
• Efficacy of Glucagon-like Peptide-1 Receptor Agonists According to Type 2 Diabetes Subtypes#146381ClinicalTrials.gov
• Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge#279681ClinicalTrials.gov
• Community Models for Hypertension and Diabetes Care for Refugees#356554ClinicalTrials.gov
• Comparative Clinical Outcomes of Nusinersen and Gene Therapy in Spinal Muscular Atrophy Type 1#325999HAL (France)
• Comparison of Two Different Insulin Dose Calculation Algorithms in Type 1 Diabetes#343776ClinicalTrials.gov
• HIT on Hypoglycemic Risk in Type 1 Diabetes (T1D)#67763ClinicalTrials.gov